Compare · NAGE vs VGR
NAGE vs VGR
Side-by-side comparison of Niagen Bioscience Inc. (NAGE) and Vector Group Ltd. (VGR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NAGE and VGR operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- VGR is the larger of the two at $1.74B, about 6.6x NAGE ($261.2M).
- NAGE has hit the wire 18 times in the past 4 weeks while VGR has been quiet.
- VGR has more recent analyst coverage (4 ratings vs 1 for NAGE).
- Company
- Niagen Bioscience Inc.
- Vector Group Ltd.
- Price
- $3.27-3.96%
- $14.99+0.20%
- Market cap
- $261.2M
- $1.74B
- 1M return
- -4.94%
- -
- 1Y return
- -67.85%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 18
- 0
- Recent ratings
- 1
- 4
Vector Group Ltd.
Vector Group Ltd., through its subsidiaries, manufactures and sells cigarettes in the United States. It operates in two segments, Tobacco and Real Estate. The company produces cigarettes in 100 combinations under the EAGLE 20's, Pyramid, Montego, Grand Prix, Liggett Select, Eve, and USA brand names, as well as various partner and private label brands. In addition, it provides residential real estate brokerage, relocation, real estate sales and marketing, and title insurance services to real estate buyers and financial institutions; manages cooperative apartment buildings, condominium apartment buildings, and rental apartment buildings; and invests in, acquires, and owns real estate properties or projects, as well as develops land. Further, the company operates elliman.com, a website that enables consumers to search properties and access current market information, as well as offers building and neighborhood guides, and other interactive content. It markets and sells its cigarettes to wholesalers and distributors of tobacco and convenience products, as well as grocery, drug, and convenience store chains. The company was formerly known as Brooke Group Ltd. and changed its name to Vector Group Ltd. in May 2000. Vector Group Ltd. was founded in 1873 and is based in Miami, Florida.
Latest NAGE
- Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research
- Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)
- SEC Form 424B5 filed by Niagen Bioscience Inc.
- SEC Form EFFECT filed by Niagen Bioscience Inc.
- Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026
- SVP, General Counsel Lopez Carlos Luis was granted 2,314 shares, increasing direct ownership by 103% to 4,565 units (SEC Form 4)
- Chief Financial Officer Pamir Ozan was granted 4,255 shares, increasing direct ownership by 58% to 11,627 units (SEC Form 4)
- Chief Executive Officer Fried Robert N was granted 1,106 shares, increasing direct ownership by 0.10% to 1,060,087 units (SEC Form 4)
- Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases
- Niagen Bioscience Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
Latest VGR
- SEC Form 15-12G filed by Vector Group Ltd.
- Amendment: SEC Form SC 13D/A filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.
- SEC Form EFFECT filed by Vector Group Ltd.